Implications of expansion of Alzheimer's biomarker testing for patients, families and policy

Advances successful probe person identified biomarker tests that marque it imaginable to observe signs of neurodegenerative conditions specified arsenic Alzheimer's illness years earlier symptoms appear, creating caller opportunities for earlier intervention—and caller questions for clinicians, patients and families.